Literature DB >> 15508166

Human myeloperoxidase: a potential target for molecular MR imaging in atherosclerosis.

John W Chen1, Wellington Pham, Ralph Weissleder, Alexei Bogdanov.   

Abstract

Plaque rupture in atherosclerotic disease is the major cause of morbidity and correlates well with myeloperoxidase (MPO) secretion by activated neutrophils and macrophages in humans. We hypothesized that paramagnetic electron donor compounds that rapidly oxidize and polymerize in the presence of MPO could be designed to enable imaging of local MPO activity levels in arterial segments at risk. Several potential substrates for MPO were synthesized and tested. One lead compound consisting of a covalent conjugate of GdDOTA and serotonin (3-(2-aminoethyl)-5-hydroxyindole) was efficiently polymerized in the presence of human neutrophil MPO resulting in a 70-100% increase in proton relaxivity. As a result, we were able to demonstrate MPO activity in enzyme solutions and in a model tissue-like system. These studies suggest that activatable paramagnetic MR imaging agents can be used to directly image MPO activity. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15508166     DOI: 10.1002/mrm.20270

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  37 in total

Review 1.  Targeted probes for cardiovascular MRI.

Authors:  Ritika Uppal; Peter Caravan
Journal:  Future Med Chem       Date:  2010-03       Impact factor: 3.808

Review 2.  Gene expression and gene therapy imaging.

Authors:  Claire Rome; Franck Couillaud; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2006-09-12       Impact factor: 5.315

Review 3.  Lanthanide probes for bioresponsive imaging.

Authors:  Marie C Heffern; Lauren M Matosziuk; Thomas J Meade
Journal:  Chem Rev       Date:  2013-12-13       Impact factor: 60.622

Review 4.  Smart MR imaging agents relevant to potential neurologic applications.

Authors:  C S Bonnet; E Tóth
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

5.  Myeloperoxidase activity imaging using (67)Ga labeled substrate.

Authors:  Manel Querol Sans; John W Chen; Ralph Weissleder; Alexei A Bogdanov
Journal:  Mol Imaging Biol       Date:  2005 Nov-Dec       Impact factor: 3.488

Review 6.  Basic MR relaxation mechanisms and contrast agent design.

Authors:  Luis M De León-Rodríguez; André F Martins; Marco C Pinho; Neil M Rofsky; A Dean Sherry
Journal:  J Magn Reson Imaging       Date:  2015-05-14       Impact factor: 4.813

7.  Molecular MRI of Atherosclerotic Plaque With Targeted Contrast Agents.

Authors:  David E Sosnovik; Peter Caravan
Journal:  Curr Cardiovasc Imaging Rep       Date:  2009-04-01

Review 8.  Recent developments and new perspectives on imaging of atherosclerotic plaque: role of anatomical, cellular and molecular MRI part III.

Authors:  Bernard C M te Boekhorst; Maarten-Jan M Cramer; Gerard Pasterkamp; Cees J A van Echteld; Pieter A F M Doevendans
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-08       Impact factor: 2.357

9.  Gadolinium-Based Contrast Agents for Vessel Wall Magnetic Resonance Imaging (MRI) of Atherosclerosis.

Authors:  Claudia Calcagno; Sarayu Ramachandran; Antoine Millon; Philip M Robson; Venkatesh Mani; Zahi Fayad
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-10-14

10.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.